Novo Nordisk shares pop 5% after Wegovy pill trial shows ‘significant’ weight reduction – CNBC By Weight Loss Novo Nordisk shares pop 5% after Wegovy pill trial shows ‘significant’ weight reduction CNBC Novo Nordisk aims for FDA approval of weight loss pill NBC News Novo Nordisk shares shoot up amid promising results for anti-obesity pill The Guardian Brought to you by Google News. Read the rest of the article here. Facebook Twitter Pinterest